| 2001 | Chicken liking | GCST90094732 | 6.62 |
| 2002 | VAT1 levels | GCST90471029 | 6.62 |
| 2003 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T412 | ECGU000412 | 6.62 |
| 2004 | IDP dMRI ProbtrackX OD fmi | GCST90004461 | 6.61 |
| 2005 | Clinical LDL cholesterol levels | GCST90497223 | 6.61 |
| 2006 | platelet count (minimum, inv-norm transformed) | GCST90476302 | 6.60 |
| 2007 | Feeling nervous | GCST006948 | 6.60 |
| 2008 | Hearing aid user (UKB data field 3393) | GCST90043741 | 6.60 |
| 2009 | Triacylglycerol_58:7_[M+NH4]1+ levels | GCST90060564 | 6.60 |
| 2010 | CRACR2A/IRAG2 ratio | GCST90314227 | 6.59 |
| 2011 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500593 | 6.59 |
| 2012 | APLP1 levels | GCST90468330 | 6.59 |
| 2013 | F-deep fried food liking (derived food-liking factor) | GCST90094753 | 6.59 |
| 2014 | Parental longevity (combined parental age at death) | GCST006702 | 6.59 |
| 2015 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 6.59 |
| 2016 | ThalamNuclei rh volume Pf | GCST90002746 | 6.58 |
| 2017 | Recent trouble relaxing | Anxiety | UKBB00000745 | 6.58 |
| 2018 | CMC1 levels | GCST90468794 | 6.57 |
| 2019 | Total lipid levels in large VLDL | GCST90092874 | 6.57 |
| 2020 | IDP dMRI TBSS ICVF Cerebral peduncle L | GCST90004342 | 6.57 |
| 2021 | CNTNAP2/DPP6 ratio | GCST90314168 | 6.57 |
| 2022 | Triglycerides to Total Lipids in Very Small VLDL percentage | GCST90500886 | 6.57 |
| 2023 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398 | ECGU000398 | 6.56 |
| 2024 | Triglyceride levels (MTAG) | GCST90179149 | 6.56 |
| 2025 | Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000236 | 6.56 |
| 2026 | SNX2 levels | GCST90470701 | 6.56 |
| 2027 | TST levels | GCST90470982 | 6.56 |
| 2028 | Rhodanobacter abundance in stool | GCST90032536 | 6.56 |
| 2029 | Reticulocyte count | GCST90002405 | 6.56 |
| 2030 | Triglyceride levels in very large VLDL | GCST90093026 | 6.55 |
| 2031 | Cholesteryl Esters in Large LDL | GCST90497949 | 6.55 |
| 2032 | Ever smoked | Smoking | UKBB00000221 | 6.55 |
| 2033 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 6.54 |
| 2034 | ICD10 N97.8: Female infertility of other origin | GCST90454225 | 6.54 |
| 2035 | PPP1R12A levels | GCST90470300 | 6.54 |
| 2036 | Joint pain (confirmatory factor analysis Factor 14) | GCST90309348 | 6.53 |
| 2037 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | GCST90269681 | 6.53 |
| 2038 | Lamb liking | GCST90094790 | 6.53 |
| 2039 | Blood cell traits latent factor 10 (platelet) | GCST90559252 | 6.53 |
| 2040 | Sphingomyelins levels | GCST90499983 | 6.53 |
| 2041 | ACY1/DCXR ratio | GCST90313162 | 6.52 |
| 2042 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90093044 | 6.52 |
| 2043 | BA-exvivo lh volume BA3b | GCST90002838 | 6.52 |
| 2044 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77 | ECGA000077 | 6.51 |
| 2045 | Phospholipid levels in small VLDL | GCST90092976 | 6.51 |
| 2046 | LAT levels | GCST90469741 | 6.50 |
| 2047 | Total lipids in medium LDL (UKB data field 23538) | GCST90269635 | 6.50 |
| 2048 | X-25371 levels | GCST90200656 | 6.50 |
| 2049 | CHRDL1 levels | GCST90468750 | 6.50 |
| 2050 | End-diastolic bi-ventricular shape (principal component 1) | GCST90448480 | 6.49 |
| 2051 | CD274 levels | GCST90468613 | 6.49 |
| 2052 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499299 | 6.49 |
| 2053 | Right ventricular peak ejection rate | GCST90268120 | 6.49 |
| 2054 | Saturated fatty acids to total fatty acids percentage | GCST90499958 | 6.49 |
| 2055 | Total lipid levels in medium LDL | GCST90092910 | 6.49 |
| 2056 | Apples liking | GCST90094691 | 6.48 |
| 2057 | Chronic lung diseases including COPD, Emphysema and Bronchitis | GCST90475272 | 6.47 |
| 2058 | Phospholipids in medium LDL (UKB data field 23539) | GCST90269636 | 6.47 |
| 2059 | IDP dMRI TBSS ICVF Superior corona radiata L | GCST90004352 | 6.47 |
| 2060 | Fracture at wrist and hand level | FING00000551 | 6.46 |
| 2061 | RRM2B/SMAD1 ratio | GCST90315788 | 6.46 |
| 2062 | DARS1/USP8 ratio | GCST90314407 | 6.46 |
| 2063 | CD58/ROR1 ratio | GCST90313854 | 6.45 |
| 2064 | Free cholesterol levels in very large VLDL | GCST90093020 | 6.45 |
| 2065 | Worry too long after an embarrassing experience | GCST006946 | 6.45 |
| 2066 | MGLL/PLA2G4A ratio | GCST90315439 | 6.44 |
| 2067 | CNPY4/ERBIN ratio | GCST90314148 | 6.44 |
| 2068 | Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivity | GCST90302744 | 6.44 |
| 2069 | Other joint disorders | FING00001064 | 6.44 |
| 2070 | Fruit liking | GCST90094766 | 6.43 |
| 2071 | CRIM1/NRP2 ratio | GCST90314261 | 6.43 |
| 2072 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499373 | 6.42 |
| 2073 | DTI TBSS MD Posterior corona radiata L | GCST90384599 | 6.42 |
| 2074 | FCGR2B levels | GCST90469201 | 6.42 |
| 2075 | Triacylglycerol_46:5_[M+NH4]1+ levels | GCST90060356 | 6.42 |
| 2076 | CD302/CD99 ratio | GCST90313805 | 6.42 |
| 2077 | Lifespan | GCST90551884 | 6.42 |
| 2078 | NUCB2/RSPO3 ratio | GCST90315575 | 6.42 |
| 2079 | Cholesterol in Large HDL | GCST90497719 | 6.41 |
| 2080 | Phosphatidylinositol-O_36:0_[M-H]1- levels | GCST90060480 | 6.40 |
| 2081 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T402 | ECGU000402 | 6.40 |
| 2082 | CHMP1A/EREG ratio | GCST90314048 | 6.40 |
| 2083 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103) | GCST90320922 | 6.39 |
| 2084 | Triglycerides to total lipids ratio in small HDL | GCST90092955 | 6.39 |
| 2085 | ACP6 levels | GCST90468204 | 6.39 |
| 2086 | platelet count (mean, inv-norm transformed) | GCST90476299 | 6.39 |
| 2087 | Cholesterol, total | GCST000760 | 6.38 |
| 2088 | ASPN levels | GCST90468377 | 6.38 |
| 2089 | Cholesterol in large VLDL (UKB data field 23498) | GCST90269595 | 6.38 |
| 2090 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328 | ECGU000328 | 6.38 |
| 2091 | DCXR/SCLY ratio | GCST90314440 | 6.37 |
| 2092 | BTN2A1/IL18BP ratio | GCST90313545 | 6.37 |
| 2093 | DRG2/SEMA4D ratio | GCST90314554 | 6.37 |
| 2094 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T357 | ECGA000357 | 6.36 |
| 2095 | HNMT/SETMAR ratio | GCST90315069 | 6.36 |
| 2096 | Cholesteryl Esters in Large HDL | GCST90497753 | 6.36 |
| 2097 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500918 | 6.36 |
| 2098 | Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels | GCST90060277 | 6.35 |
| 2099 | NPY levels | GCST90470081 | 6.35 |
| 2100 | DARS1/MAP4K5 ratio | GCST90314404 | 6.35 |
| 2101 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226 | ECGU000226 | 6.34 |
| 2102 | Concentration of LDL particles (UKB data field 23429) | GCST90269526 | 6.34 |
| 2103 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T142 | ECGA000142 | 6.34 |
| 2104 | ADGRE1 levels | GCST90468236 | 6.33 |
| 2105 | ANXA11 levels | GCST90468315 | 6.33 |
| 2106 | Triacylglycerol_50:3_[M+NH4]1+ levels | GCST90060468 | 6.33 |
| 2107 | Non-oily fish consumption | GCST90132994 | 6.33 |
| 2108 | Monounsaturated fatty acid levels | GCST90502347 | 6.33 |
| 2109 | Hemoglobin concentration | GCST90002311 | 6.33 |
| 2110 | low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed) | GCST90475416 | 6.32 |
| 2111 | DLL4 levels | GCST90469005 | 6.32 |
| 2112 | ITGA6 levels | GCST90469636 | 6.32 |
| 2113 | KIFBP levels | GCST90469683 | 6.31 |
| 2114 | Free cholesterol levels in small HDL | GCST90092948 | 6.31 |
| 2115 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22 | ECGA000022 | 6.31 |
| 2116 | Pregnenediol disulfate (C21H34O8S2) levels | GCST90199840 | 6.30 |
| 2117 | Polyunsaturated fatty acid levels | GCST90502619 | 6.30 |
| 2118 | Parental longevity (combined parental attained age, Martingale residuals) | GCST006697 | 6.30 |
| 2119 | CLEC1B/LGALS8 ratio | GCST90314096 | 6.29 |
| 2120 | DTI autoptx L3 fmi tract | GCST90385204 | 6.29 |
| 2121 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11 | ECGA000011 | 6.28 |
| 2122 | ADGRE5/ITGB2 ratio | GCST90313180 | 6.28 |
| 2123 | Cereal bar liking | GCST90094728 | 6.28 |
| 2124 | Immature reticulocyte fraction (UKB data field 30280) | GCST90468079 | 6.28 |
| 2125 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82 | ECGA000082 | 6.27 |
| 2126 | FABP5/PPCDC ratio | GCST90314763 | 6.27 |
| 2127 | BCAM/SEMA7A ratio | GCST90313476 | 6.27 |
| 2128 | IDP dMRI TBSS ICVF Fornix | GCST90004332 | 6.27 |
| 2129 | Total fatty acids levels (UKB data field 23442) | GCST90269539 | 6.26 |
| 2130 | AAGAB levels | GCST90617473 | 6.26 |
| 2131 | Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000709 | 6.26 |
| 2132 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500695 | 6.26 |
| 2133 | CLIP2/NT5C3A ratio | GCST90314129 | 6.25 |
| 2134 | Left-hemisphere somatomotor network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302671 | 6.23 |
| 2135 | Concentration of medium LDL particles | GCST90092911 | 6.23 |
| 2136 | PSCA levels | GCST90470352 | 6.23 |
| 2137 | CD200 levels | GCST90468606 | 6.22 |
| 2138 | Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels | GCST90060420 | 6.22 |
| 2139 | Triacylglycerol_47:4_[M+NH4]1+ levels | GCST90060391 | 6.22 |
| 2140 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500665 | 6.22 |
| 2141 | IGFBP2 levels | GCST90469528 | 6.21 |
| 2142 | Subclinical hyperthyroidism in pregnancy | GCST90435199 | 6.21 |
| 2143 | CXCL1 levels | GCST90468930 | 6.21 |
| 2144 | ALB levels | GCST90475100 | 6.20 |
| 2145 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97 | ECGU000097 | 6.20 |
| 2146 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112) | GCST90320931 | 6.20 |
| 2147 | Concentration of large VLDL particles | GCST90092875 | 6.20 |
| 2148 | Immature reticulocyte fraction | Blood count | UKBB00000355 | 6.20 |
| 2149 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386 | ECGA000386 | 6.19 |
| 2150 | Luteinizing hormone levels | GCST90483478 | 6.18 |
| 2151 | CTSF/SMPDL3A ratio | GCST90314316 | 6.18 |
| 2152 | CTSZ/HSPG2 ratio | GCST90314318 | 6.17 |
| 2153 | HYOU1/PTPRF ratio | GCST90315102 | 6.17 |
| 2154 | Treatment/medication code - co-codamol | Medications | UKBB00000845 | 6.17 |
| 2155 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499302 | 6.16 |
| 2156 | Free cholesterol in medium LDL | GCST90498774 | 6.16 |
| 2157 | TNFRSF14/TNFRSF1A ratio | GCST90315935 | 6.16 |
| 2158 | aparc-a2009s rh volume S-central | GCST90003043 | 6.16 |
| 2159 | Diseases of sebaceous glands (PheCode 706) | GCST90476210 | 6.16 |
| 2160 | Principal component-derived dietary pattern 13 | GCST90133018 | 6.15 |
| 2161 | IDP dMRI ProbtrackX ICVF ml l | GCST90004392 | 6.15 |
| 2162 | Diacylglycerol_36:2_[M+H-H2O]1+ levels | GCST90060191 | 6.15 |
| 2163 | IDS/SMPDL3A ratio | GCST90315126 | 6.13 |
| 2164 | Left-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302736 | 6.13 |
| 2165 | Cholesterol to total lipids in large HDL percentage (UKB data field 23635) | GCST90269732 | 6.13 |
| 2166 | BCR/ICA1 ratio | GCST90313493 | 6.13 |
| 2167 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502385 | 6.13 |
| 2168 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T137 | ECGA000137 | 6.11 |
| 2169 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372 | ECGA000372 | 6.11 |
| 2170 | ERBIN/SIRT2 ratio | GCST90314696 | 6.11 |
| 2171 | CD58/IFNGR1 ratio | GCST90313849 | 6.11 |
| 2172 | CTHRC1 levels | GCST90468902 | 6.10 |
| 2173 | Triglycerides in VLDL | GCST90500304 | 6.09 |
| 2174 | HSPA1A levels | GCST90469487 | 6.09 |
| 2175 | Linoleic acid levels | GCST90502306 | 6.09 |
| 2176 | TNFSF8 levels | GCST90470923 | 6.09 |
| 2177 | aparc-pial rh area supramarginal | GCST90003204 | 6.09 |
| 2178 | Cholesterol levels in very large VLDL | GCST90093016 | 6.09 |
| 2179 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383 | ECGA000383 | 6.09 |
| 2180 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368 | ECGA000368 | 6.08 |
| 2181 | aparc-a2009s lh area Pole-temporal | GCST90003339 | 6.08 |
| 2182 | KLKB1 levels | GCST90469708 | 6.08 |
| 2183 | AZU1/CEACAM8 ratio | GCST90313424 | 6.08 |
| 2184 | Angina pectoris | circulatory system | UKBB00000030 | 6.08 |
| 2185 | LAYN/ULBP2 ratio | GCST90315292 | 6.07 |
| 2186 | CPB1/KIRREL2 ratio | GCST90314210 | 6.07 |
| 2187 | Myocardial fractal dimension (slice 2) | GCST90000288 | 6.07 |
| 2188 | Triglycerides to total lipids ratio in medium HDL | GCST90092903 | 6.07 |
| 2189 | CTSS levels | GCST90468916 | 6.06 |
| 2190 | Triglyceride levels in medium VLDL | GCST90092926 | 6.06 |
| 2191 | IDP dMRI TBSS MD External capsule L | GCST90004060 | 6.06 |
| 2192 | Other cancer | GCST90475181 | 6.05 |
| 2193 | APP/DAG1 ratio | GCST90313320 | 6.04 |
| 2194 | High light scatter reticulocyte count | GCST004611 | 6.04 |
| 2195 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384 | ECGA000384 | 6.04 |
| 2196 | CTSD/PRCP ratio | GCST90314312 | 6.04 |
| 2197 | COL18A1/RETN ratio | GCST90314170 | 6.04 |
| 2198 | CD40/CRELD2 ratio | GCST90313811 | 6.04 |
| 2199 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428 | ECGU000428 | 6.03 |
| 2200 | HLA-DRA levels | GCST90469458 | 6.03 |
| 2201 | CASP3/CRKL ratio | GCST90313631 | 6.03 |
| 2202 | Triglycerides to Total Lipids in Large LDL percentage | GCST90498101 | 6.03 |
| 2203 | CLIP2/DAB2 ratio | GCST90314124 | 6.02 |
| 2204 | Depression/anxiety (standard GWA) | GCST90267276 | 6.02 |
| 2205 | GAS6 levels | GCST90469305 | 6.02 |
| 2206 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 6.01 |
| 2207 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362 | ECGA000362 | 6.01 |
| 2208 | DNAJA2/HPCAL1 ratio | GCST90314503 | 6.01 |
| 2209 | CELA3A/CPB1 ratio | GCST90314010 | 6.00 |
| 2210 | Citrate levels | GCST90092813 | 5.99 |
| 2211 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16 | ECGA000016 | 5.99 |
| 2212 | CRELD2/ERP44 ratio | GCST90314253 | 5.99 |
| 2213 | Abdominal aortic aneurysm (AAA) | FING00000001 | 5.98 |
| 2214 | ITGB1BP2/STAT5B ratio | GCST90315220 | 5.98 |
| 2215 | Sleep disorders | Episodic and paroxysmal disorders | UKBB00000775 | 5.97 |
| 2216 | IDP dMRI TBSS L3 Middle cerebellar peduncle | GCST90004171 | 5.97 |
| 2217 | NIT1 levels | GCST90470050 | 5.97 |
| 2218 | Cholesterol to Total Lipids in Large VLDL percentage | GCST90498130 | 5.96 |
| 2219 | MCAM/NTRK3 ratio | GCST90315409 | 5.96 |
| 2220 | ThalamNuclei lh volume VAmc | GCST90002723 | 5.96 |
| 2221 | Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | GCST90500565 | 5.96 |
| 2222 | Porridge liking | GCST90094815 | 5.96 |
| 2223 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381 | ECGA000381 | 5.96 |
| 2224 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T133 | ECGA000133 | 5.96 |
| 2225 | HRC levels | GCST90469475 | 5.96 |
| 2226 | IDP dMRI TBSS OD Fornix | GCST90004407 | 5.96 |
| 2227 | SCARA5 levels | GCST90470533 | 5.95 |
| 2228 | Total triglycerides levels | GCST90092992 | 5.95 |
| 2229 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90044025 | 5.95 |
| 2230 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247 | ECGU000247 | 5.95 |
| 2231 | TBCC/WWP2 ratio | GCST90315911 | 5.95 |
| 2232 | GP2/LGALS8 ratio | GCST90314961 | 5.95 |
| 2233 | IGSF8/NECTIN2 ratio | GCST90315140 | 5.95 |
| 2234 | IL10RB levels | GCST90469545 | 5.94 |
| 2235 | Monounsaturated fatty acid levels | GCST90502362 | 5.93 |
| 2236 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180 | ECGU000180 | 5.92 |
| 2237 | IDP dMRI TBSS MD Cingulum hippocampus L | GCST90004064 | 5.92 |
| 2238 | PAMR1 levels | GCST90470155 | 5.92 |
| 2239 | IGFBP6/MFAP5 ratio | GCST90315135 | 5.91 |
| 2240 | MOG/SEZ6L ratio | GCST90315477 | 5.91 |
| 2241 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374 | ECGA000374 | 5.91 |
| 2242 | PEAR1/SNAP23 ratio | GCST90315643 | 5.91 |
| 2243 | ITGB1/MCAM ratio | GCST90315226 | 5.91 |
| 2244 | IDP dMRI TBSS ICVF Uncinate fasciculus R | GCST90004371 | 5.91 |
| 2245 | Coriander liking | GCST90094744 | 5.90 |
| 2246 | BCAN/NPTXR ratio | GCST90313482 | 5.90 |
| 2247 | BSG/TNFRSF4 ratio | GCST90313536 | 5.90 |
| 2248 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 5.89 |
| 2249 | TMSB10/TRIAP1 ratio | GCST90315924 | 5.89 |
| 2250 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26 | ECGA000026 | 5.89 |
| 2251 | JAM2/THBD ratio | GCST90315239 | 5.88 |
| 2252 | Total fatty acid levels | GCST90502723 | 5.88 |
| 2253 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499044 | 5.88 |
| 2254 | IGF2R levels | GCST90469526 | 5.88 |
| 2255 | CST3/EFEMP1 ratio | GCST90314292 | 5.88 |
| 2256 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15 | ECGA000015 | 5.88 |
| 2257 | Non-cancer illness code, self-reported - high cholesterol | Medical conditions | UKBB00000516 | 5.88 |
| 2258 | Moderate visual impairment, binocular | FING00000831 | 5.87 |
| 2259 | BA-exvivo rh volume MT | GCST90002860 | 5.87 |
| 2260 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366 | ECGA000366 | 5.86 |
| 2261 | Concentration of very small VLDL particles | GCST90093035 | 5.86 |
| 2262 | VSIR levels | GCST90471053 | 5.86 |
| 2263 | MIF levels | GCST90469906 | 5.85 |
| 2264 | aparc-pial lh area rostralmiddlefrontal | GCST90003167 | 5.85 |
| 2265 | Total lipids in small HDL (UKB data field 23573) | GCST90269670 | 5.85 |
| 2266 | SPON1 levels | GCST90470731 | 5.85 |
| 2267 | IDP dMRI TBSS FA Anterior limb of internal capsule L | GCST90003894 | 5.85 |
| 2268 | DRG2 levels | GCST90469039 | 5.85 |
| 2269 | PDLIM7/PLA2G4A ratio | GCST90315637 | 5.85 |
| 2270 | PLXNB3 levels | GCST90470267 | 5.84 |
| 2271 | Total lipid levels in very large VLDL | GCST90093022 | 5.84 |
| 2272 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367 | ECGA000367 | 5.84 |
| 2273 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371 | ECGA000371 | 5.84 |
| 2274 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499635 | 5.83 |
| 2275 | Free cholesterol levels in small VLDL | GCST90092972 | 5.83 |
| 2276 | ICAM2/IL7R ratio | GCST90315117 | 5.83 |
| 2277 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 5.83 |
| 2278 | Body mass index | GCST90103751 | 5.83 |
| 2279 | MATN2/SCARA5 ratio | GCST90315388 | 5.81 |
| 2280 | DTI autoptx L3 ptr r tract | GCST90385213 | 5.81 |
| 2281 | IDP dMRI TBSS L2 Superior cerebellar peduncle L | GCST90004136 | 5.81 |
| 2282 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385 | ECGA000385 | 5.81 |
| 2283 | CXCL6/DFFA ratio | GCST90314357 | 5.80 |
| 2284 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502648 | 5.79 |
| 2285 | GP1BA levels | GCST90469380 | 5.79 |
| 2286 | AKR7L levels | GCST90468275 | 5.79 |
| 2287 | DTI autoptx L3 str l tract | GCST90385216 | 5.79 |
| 2288 | Cholesterol levels in medium LDL | GCST90092904 | 5.78 |
| 2289 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53 | ECGA000053 | 5.78 |
| 2290 | Phospholipid levels in very small VLDL | GCST90093036 | 5.78 |
| 2291 | IDP dMRI ProbtrackX OD slf l | GCST90004471 | 5.78 |
| 2292 | IDP dMRI TBSS ICVF Superior corona radiata R | GCST90004351 | 5.78 |
| 2293 | HSPG2/PTGDS ratio | GCST90315092 | 5.78 |
| 2294 | Chronic nephritic syndrome | FING00000295 | 5.77 |
| 2295 | Concentration of very large VLDL particles | GCST90500631 | 5.76 |
| 2296 | GRHPR levels | GCST90469400 | 5.76 |
| 2297 | Diacylglycerol_34:2_[M+H-H2O]1+ levels | GCST90060178 | 5.76 |
| 2298 | ANG/F9 ratio | GCST90313259 | 5.75 |
| 2299 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | GCST90200041 | 5.75 |
| 2300 | GAL levels | GCST90012062 | 5.75 |
| 2301 | Total lipids in very small VLDL | GCST90500813 | 5.75 |
| 2302 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373 | ECGA000373 | 5.75 |
| 2303 | APOB levels | GCST90269536 | 5.75 |
| 2304 | Cholesteryl esters in large VLDL (UKB data field 23499) | GCST90269596 | 5.75 |
| 2305 | CKAP2 levels | GCST90240866 | 5.75 |
| 2306 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429 | ECGU000429 | 5.73 |
| 2307 | Triglyceride levels (UKB data field 30870) | GCST90468106 | 5.73 |
| 2308 | Linoleic acid to total fatty acids percentage | GCST90498321 | 5.73 |
| 2309 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T410 | ECGU000410 | 5.72 |
| 2310 | Hereditary ataxia | FING00000610 | 5.72 |
| 2311 | FCGR3B levels | GCST90469202 | 5.72 |
| 2312 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476363 | 5.72 |
| 2313 | GLRX5 levels | GCST90469361 | 5.71 |
| 2314 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T110 | ECGA000110 | 5.71 |
| 2315 | CDKN1A/ENO2 ratio | GCST90313969 | 5.71 |
| 2316 | ROBO2/SCARF2 ratio | GCST90315784 | 5.70 |
| 2317 | Concentration of very large VLDL particles | GCST90093023 | 5.70 |
| 2318 | Modified Stumvoll Insulin Sensitivity Index (adjusted for BMI) | GCST90267573 | 5.70 |
| 2319 | Cholesteryl Esters to Total Lipids in Large VLDL percentage | GCST90498165 | 5.70 |
| 2320 | COL5A1 levels | GCST90468820 | 5.69 |
| 2321 | Phospholipids in VLDL | GCST90500268 | 5.69 |
| 2322 | LCAT levels | GCST90469745 | 5.69 |
| 2323 | IDP dMRI TBSS L1 Splenium of corpus callosum | GCST90004079 | 5.68 |
| 2324 | Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5) | GCST90132973 | 5.68 |
| 2325 | Linoleic acid to total fatty acids percentage | GCST90498328 | 5.68 |
| 2326 | Linoleic acid to total fatty acids percentage | GCST90502336 | 5.67 |
| 2327 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382 | ECGA000382 | 5.67 |
| 2328 | Concentration of small LDL particles | GCST90092963 | 5.67 |
| 2329 | Cholesteryl ester levels in small LDL | GCST90092958 | 5.66 |
| 2330 | Free cholesterol in IDL | GCST90497564 | 5.66 |
| 2331 | Tea with sugar liking | GCST90094857 | 5.65 |
| 2332 | Left bundle branch block (PheCode 426.32) | GCST90475958 | 5.64 |
| 2333 | ThalamNuclei lh volume L-Sg | GCST90002716 | 5.64 |
| 2334 | EIF4G1/HEXIM1 ratio | GCST90314635 | 5.63 |
| 2335 | CRTAC1 levels | GCST90468870 | 5.63 |
| 2336 | Total lipids in large LDL | GCST90498021 | 5.63 |
| 2337 | FAP/LRRN1 ratio | GCST90314783 | 5.62 |
| 2338 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498293 | 5.62 |
| 2339 | Concentration of small HDL particles | GCST90499464 | 5.62 |
| 2340 | CRADD levels | GCST90468854 | 5.62 |
| 2341 | Phosphatidate_34:2_[M-H]1- levels | GCST90060223 | 5.62 |
| 2342 | ACAN levels | GCST90468196 | 5.61 |
| 2343 | ACHE levels | GCST90468199 | 5.61 |
| 2344 | Arthropathy in ulcerative colitis | FING00000110 | 5.61 |
| 2345 | SH3BP1 levels | GCST90470619 | 5.61 |
| 2346 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 5.60 |
| 2347 | GAPDH levels | GCST90469302 | 5.60 |
| 2348 | LDL (weighted GWA) | GCST90267273 | 5.60 |
| 2349 | DTI autoptx L3 slf r tract | GCST90385215 | 5.59 |
| 2350 | NUDT2 levels | GCST90470106 | 5.59 |
| 2351 | Osteoarthritis (hip) | GCST007091 | 5.59 |
| 2352 | Atherosclerosis of the extremities (PheCode 440.2) | GCST90475990 | 5.58 |
| 2353 | CA12 levels | GCST90468507 | 5.58 |
| 2354 | Osteoarthritis of the hip or knee | GCST007092 | 5.58 |
| 2355 | IFNGR1/IL10RB ratio | GCST90315127 | 5.58 |
| 2356 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497929 | 5.58 |
| 2357 | 10-undecenoate (11:1n1) levels | GCST90243596 | 5.58 |
| 2358 | SUGT1 levels | GCST90470780 | 5.57 |
| 2359 | UBE2L6 levels | GCST90471001 | 5.57 |
| 2360 | IDI2 levels | GCST90469505 | 5.57 |
| 2361 | Concentration of medium LDL particles | GCST90498819 | 5.57 |
| 2362 | Current employment status - Doing unpaid or voluntary work | Employment | UKBB00000157 | 5.57 |
| 2363 | Immature fraction of reticulocytes | GCST90025971 | 5.57 |
| 2364 | CLEC1B/ITGB5 ratio | GCST90314094 | 5.56 |
| 2365 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498204 | 5.56 |
| 2366 | Total triglycerides levels | GCST90500126 | 5.56 |
| 2367 | Phosphatidylcholines levels (UKB data field 23437) | GCST90269534 | 5.56 |
| 2368 | Concentration of very small VLDL particles | GCST90500826 | 5.56 |
| 2369 | Artrosis, including avohilmo | FING00000112 | 5.55 |
| 2370 | triglyceride (minimum, inv-norm transformed) | GCST90476439 | 5.55 |
| 2371 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86 | ECGA000086 | 5.55 |
| 2372 | EIF4E levels | GCST90469096 | 5.54 |
| 2373 | Monounsaturated fatty acid levels | GCST90502359 | 5.54 |
| 2374 | Phosphatidylcholine diacyl C38:3 levels | GCST90240045 | 5.53 |
| 2375 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13) | GCST90320576 | 5.53 |
| 2376 | Concentration of small VLDL particles | GCST90092975 | 5.53 |
| 2377 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498252 | 5.53 |
| 2378 | Saturated fatty acids levels | GCST90502658 | 5.52 |
| 2379 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 5.52 |
| 2380 | GPD1 levels | GCST90469388 | 5.52 |
| 2381 | LDLR levels | GCST90179346 | 5.52 |
| 2382 | Free Cholesterol in VLDL | GCST90500217 | 5.51 |
| 2383 | Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels | GCST90060318 | 5.51 |
| 2384 | Free cholesterol in VLDL (UKB data field 23420) | GCST90269517 | 5.51 |
| 2385 | INSR levels | GCST90241509 | 5.51 |
| 2386 | Metabolic disorders | FING00000816 | 5.49 |
| 2387 | PMM2 levels | GCST90470270 | 5.49 |
| 2388 | Acute pancreatitis | GCST90018569 | 5.48 |
| 2389 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387 | ECGA000387 | 5.48 |
| 2390 | Neurociticism | GCST006940 | 5.48 |
| 2391 | CFH levels | GCST90468729 | 5.48 |
| 2392 | CD164/NUDT5 ratio | GCST90313742 | 5.48 |
| 2393 | PECAM1 levels | GCST90470206 | 5.47 |
| 2394 | F5 levels | GCST90446466 | 5.47 |
| 2395 | BMI (standard GWA) | GCST90267268 | 5.47 |
| 2396 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320674 | 5.46 |
| 2397 | Abnormalities of forces of labour | FING00000003 | 5.46 |
| 2398 | Platelet count (UKB data field 30080) | GCST90468095 | 5.46 |
| 2399 | HippSubfield lh volume subiculum-body | GCST90002669 | 5.45 |
| 2400 | Free cholesterol in small HDL (UKB data field 23577) | GCST90269674 | 5.45 |
| 2401 | PSME1 levels | GCST90470360 | 5.45 |
| 2402 | BA-exvivo lh thickness BA2 | GCST90003514 | 5.45 |
| 2403 | Omega-3 fatty acids levels | GCST90499139 | 5.44 |
| 2404 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175 | ECGU000175 | 5.44 |
| 2405 | CD69/TXNDC5 ratio | GCST90313889 | 5.44 |
| 2406 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370 | ECGA000370 | 5.44 |
| 2407 | Free cholesterol levels in large VLDL | GCST90092872 | 5.43 |
| 2408 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499800 | 5.43 |
| 2409 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167 | ECGA000167 | 5.43 |
| 2410 | SPINK5 levels | GCST90470724 | 5.43 |
| 2411 | Back pain | symptoms | UKBB00000084 | 5.42 |
| 2412 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T397 | ECGU000397 | 5.42 |
| 2413 | rfMRI amplitudes (ICA100 node 35) | GCST90004623 | 5.42 |
| 2414 | PSRC1/SORT1 ratio | GCST90315742 | 5.42 |
| 2415 | Triglycerides to Total Lipids in Large LDL percentage | GCST90498092 | 5.42 |
| 2416 | NUBP1 levels | GCST90470100 | 5.41 |
| 2417 | TBCA levels | GCST90470812 | 5.41 |
| 2418 | Strawberries liking | GCST90094849 | 5.41 |
| 2419 | DNAJA2/HCLS1 ratio | GCST90314502 | 5.40 |
| 2420 | INPP1/TBCC ratio | GCST90315180 | 5.40 |
| 2421 | Total lipids in very large VLDL | GCST90500614 | 5.40 |
| 2422 | Clonal haematopoiesis of indeterminate potential (ASXL1 mutation) | GCST90165259 | 5.39 |
| 2423 | APP/NID1 ratio | GCST90313326 | 5.39 |
| 2424 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363 | ECGA000363 | 5.39 |
| 2425 | ITIH3/VCAM1 ratio | GCST90315236 | 5.38 |
| 2426 | CNTN4 levels | GCST90468806 | 5.38 |
| 2427 | Phospholipid levels in medium LDL | GCST90092912 | 5.38 |
| 2428 | IDP dMRI TBSS ISOVF External capsule R | GCST90004509 | 5.38 |
| 2429 | Cholesterol to Total Lipids in IDL percentage | GCST90497518 | 5.38 |
| 2430 | Degree of unsaturation | GCST90502752 | 5.37 |
| 2431 | Total lipid levels in small VLDL | GCST90092974 | 5.37 |
| 2432 | Cerebrospinal fluid S-1-pyrroline-5-carboxylate levels | GCST90318235 | 5.36 |
| 2433 | CST3/IL18BP ratio | GCST90314294 | 5.36 |
| 2434 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 5.36 |
| 2435 | Sphingomyelin_41:0_[M+H]1+ levels | GCST90060386 | 5.36 |
| 2436 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 5.35 |
| 2437 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497549 | 5.35 |
| 2438 | Glycoprotein acetyls levels | GCST90497328 | 5.35 |
| 2439 | GP6/LGALS8 ratio | GCST90314964 | 5.35 |
| 2440 | CD84 levels | GCST90468653 | 5.35 |
| 2441 | PNLIPRP2 levels | GCST90470274 | 5.34 |
| 2442 | PCDH12 levels | GCST90470168 | 5.34 |
| 2443 | aparc-pial lh area TotalSurface | GCST90003141 | 5.33 |
| 2444 | triglyceride (mean, inv-norm transformed) | GCST90476435 | 5.33 |
| 2445 | FCN1 levels | GCST90469203 | 5.33 |
| 2446 | STIP1 levels | GCST90470764 | 5.33 |
| 2447 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245 | ECGU000245 | 5.33 |
| 2448 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T400 | ECGU000400 | 5.32 |
| 2449 | Total lipid levels in very small VLDL | GCST90093034 | 5.31 |
| 2450 | GC levels | GCST90162564 | 5.31 |
| 2451 | COL3A1 levels | GCST90468817 | 5.31 |
| 2452 | Phosphatidylcholine levels | GCST90092937 | 5.30 |
| 2453 | NUB1/SRPK2 ratio | GCST90315573 | 5.30 |
| 2454 | HMOX2/TDRKH ratio | GCST90315067 | 5.30 |
| 2455 | ENPP7 levels | GCST90469118 | 5.29 |
| 2456 | MGMT levels | GCST90469902 | 5.29 |
| 2457 | Omega-6 fatty acid levels | GCST90502514 | 5.29 |
| 2458 | Angina pectoris (PheCode 411.3) | GCST90475933 | 5.28 |
| 2459 | Leucine levels | GCST90092891 | 5.28 |
| 2460 | MMP9/OLR1 ratio | GCST90315467 | 5.27 |
| 2461 | RELT/TNFRSF1A ratio | GCST90315767 | 5.27 |
| 2462 | Platelet count | GCST90002402 | 5.27 |
| 2463 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T401 | ECGU000401 | 5.27 |
| 2464 | Liver fat | GCST90029073 | 5.27 |
| 2465 | CDH5/PCDH17 ratio | GCST90313958 | 5.26 |
| 2466 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 5.25 |
| 2467 | Cholesterol in small LDL (UKB data field 23547) | GCST90269644 | 5.25 |
| 2468 | MAP2K6/MGMT ratio | GCST90315373 | 5.25 |
| 2469 | IDP dMRI ProbtrackX ICVF cgh l | GCST90004381 | 5.24 |
| 2470 | Total lipids in medium VLDL | GCST90498994 | 5.24 |
| 2471 | Triacylglycerol_54:4_[M+NH4]1+ levels | GCST90060540 | 5.24 |
| 2472 | IDP dMRI TBSS FA Fornix | GCST90003882 | 5.24 |
| 2473 | DAPP1 levels | GCST90468946 | 5.23 |
| 2474 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256 | ECGU000256 | 5.23 |
| 2475 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177 | ECGU000177 | 5.23 |
| 2476 | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | GCST90302674 | 5.23 |
| 2477 | IDP dMRI ProbtrackX ICVF ilf r | GCST90004390 | 5.23 |
| 2478 | Other functional intestinal disorders | FING00001052 | 5.23 |
| 2479 | aseg global volume SupraTentorialNotVent | GCST90002596 | 5.22 |
| 2480 | Recent feelings or nervousness or anxiety | Anxiety | UKBB00000741 | 5.22 |
| 2481 | Congestive heart failure | GCST90475200 | 5.21 |
| 2482 | HNRNPK levels | GCST90469469 | 5.21 |
| 2483 | 1-linoleoyl-GPI (18:2) levels | GCST90199821 | 5.21 |
| 2484 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229 | ECGU000229 | 5.21 |
| 2485 | CD99L2/RARRES2 ratio | GCST90313927 | 5.21 |
| 2486 | Retinal thickness (functional principal component 4) | GCST90455724 | 5.20 |
| 2487 | Phospholipid levels in very large VLDL | GCST90093024 | 5.20 |
| 2488 | Blood cell traits latent factor 14 (red cell) | GCST90559256 | 5.20 |
| 2489 | IDP dMRI TBSS MD Fornix | GCST90004032 | 5.19 |
| 2490 | Omega-6 fatty acid levels | GCST90502518 | 5.19 |
| 2491 | Other strabismus | FING00001114 | 5.19 |
| 2492 | Diacylglycerol_36:3_[M+H-H2O]1+ levels | GCST90060189 | 5.19 |
| 2493 | KDR levels | GCST90243323 | 5.18 |
| 2494 | Monounsaturated fatty acid levels | GCST90499094 | 5.18 |
| 2495 | Sitting height | Body size measures | UKBB00000771 | 5.18 |
| 2496 | ARHGEF10 levels | GCST90468357 | 5.18 |
| 2497 | FKBP5/MAP4K5 ratio | GCST90314843 | 5.18 |
| 2498 | Linoleic acid levels | GCST90502004 | 5.17 |
| 2499 | APBB1IP/POLR2F ratio | GCST90313300 | 5.17 |
| 2500 | aseg global volume VentricleChoroid | GCST90002598 | 5.17 |
| 2501 | CD177 levels | GCST90468603 | 5.16 |
| 2502 | Left-hemisphere salience/ventral attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302711 | 5.16 |
| 2503 | SORD levels | GCST90470709 | 5.15 |
| 2504 | Hereditary corneal dystrophies | FING00000611 | 5.15 |
| 2505 | Non-oily fish intake | Diet | UKBB00000525 | 5.14 |
| 2506 | Cholesteryl esters in VLDL (UKB data field 23416) | GCST90269513 | 5.14 |
| 2507 | Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental health | UKBB00000338 | 5.14 |
| 2508 | Concentration of small VLDL particles | GCST90499856 | 5.14 |
| 2509 | BLVRB/HBQ1 ratio | GCST90313525 | 5.14 |
| 2510 | CFI levels | GCST90468730 | 5.14 |
| 2511 | Alkaline phosphatase | Blood biochemistry | UKBB00000027 | 5.14 |
| 2512 | Concentration of LDL particles | GCST90092887 | 5.14 |
| 2513 | Liver condition (ex. cirrhosis) | GCST90475270 | 5.14 |
| 2514 | Phlebitis and thrombophlebitis (PheCode 451) | GCST90476003 | 5.13 |
| 2515 | HDL cholesterol | GCST90018736 | 5.13 |
| 2516 | Monounsaturated fatty acid levels | GCST90499090 | 5.13 |
| 2517 | Liver enzyme levels (alkaline phosphatase) | GCST90013406 | 5.13 |
| 2518 | CRELD2/TXNDC5 ratio | GCST90314259 | 5.13 |
| 2519 | FGF19 levels | GCST90469220 | 5.12 |
| 2520 | Malignant neoplasm of liver, primary (PheCode 155.1) | GCST90475569 | 5.12 |
| 2521 | Red blood cell count | GCST90002364 | 5.12 |
| 2522 | VLDL cholesterol levels (UKB data field 23403) | GCST90269500 | 5.12 |
| 2523 | aparc-a2009s rh volume S-oc-middle+Lunatus | GCST90003055 | 5.12 |
| 2524 | SMAD1/ZBTB16 ratio | GCST90315853 | 5.12 |
| 2525 | ITGB1/NCAM1 ratio | GCST90315227 | 5.12 |
| 2526 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 5.11 |
| 2527 | Omega-3 fatty acid levels | GCST90502064 | 5.11 |
| 2528 | aparc-DKTatlas lh thickness precentral | GCST90003562 | 5.11 |
| 2529 | Saturated fatty acids levels | GCST90502194 | 5.10 |
| 2530 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 5.10 |
| 2531 | Retinoschisis and retinal cysts (PheCode 361.2) | GCST90475846 | 5.10 |
| 2532 | PLAU/PLAUR ratio | GCST90315674 | 5.09 |
| 2533 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T407 | ECGU000407 | 5.09 |
| 2534 | GAL/PM20D1 ratio | GCST90314917 | 5.08 |
| 2535 | CA13/TIA1 ratio | GCST90313567 | 5.08 |
| 2536 | Carnitine levels | GCST90239991 | 5.08 |
| 2537 | MSRA/PRDX5 ratio | GCST90315497 | 5.08 |
| 2538 | TACSTD2 levels | GCST90470798 | 5.07 |
| 2539 | Free cholesterol levels in very small VLDL | GCST90093032 | 5.07 |
| 2540 | IDP dMRI ProbtrackX ICVF str r | GCST90004399 | 5.07 |
| 2541 | aseg lh volume Lateral-Ventricle | GCST90002616 | 5.07 |
| 2542 | Monounsaturated fatty acid levels | GCST90502346 | 5.06 |
| 2543 | FUS levels | GCST90469278 | 5.06 |
| 2544 | platelet count (maximum, inv-norm transformed) | GCST90476296 | 5.06 |
| 2545 | Age-related hearing impairment (MTAG) | GCST90012115 | 5.06 |
| 2546 | BA-exvivo lh volume BA6 | GCST90002841 | 5.06 |
| 2547 | Abdominal pain | symptoms | UKBB00000003 | 5.06 |
| 2548 | DTI autoptx MD cgc r tract | GCST90385225 | 5.05 |
| 2549 | CPA1 levels | GCST90468836 | 5.05 |
| 2550 | IDP dMRI TBSS ISOVF Anterior corona radiata R | GCST90004499 | 5.05 |
| 2551 | TDRKH/TST ratio | GCST90315913 | 5.05 |
| 2552 | DCTN1/ERBIN ratio | GCST90314429 | 5.05 |
| 2553 | CAG-177 abundance in stool | GCST90032261 | 5.05 |
| 2554 | Right-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivity | GCST90302821 | 5.05 |
| 2555 | ASPSCR1 levels | GCST90468378 | 5.05 |
| 2556 | TDP1 levels | GCST90470826 | 5.05 |
| 2557 | CD164/PARK7 ratio | GCST90313743 | 5.04 |
| 2558 | CDKN1A/FOXO1 ratio | GCST90313970 | 5.04 |
| 2559 | 1-arachidonoylglycerophosphocholine levels | GCST90243674 | 5.04 |
| 2560 | IDP dMRI TBSS FA Posterior limb of internal capsule L | GCST90003896 | 5.04 |
| 2561 | Wegener granulomatosis | FING00001446 | 5.03 |
| 2562 | Sleep disorders | neurological | UKBB00000776 | 5.03 |
| 2563 | LBR/LGALS8 ratio | GCST90315294 | 5.03 |
| 2564 | Anterior thigh muscle volume | GCST90267349 | 5.03 |
| 2565 | CDKN1A/DAB2 ratio | GCST90313967 | 5.03 |
| 2566 | aparc-Desikan lh thickness precentral | GCST90003468 | 5.02 |
| 2567 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369 | ECGA000369 | 5.01 |
| 2568 | Concentration of large VLDL particles | GCST90498223 | 5.00 |
| 2569 | Ascending aorta diameter | GCST90091050 | 5.00 |
| 2570 | AMY1A or AMY1B or AMY1C levels | GCST90468297 | 5.00 |
| 2571 | PEPD levels | GCST90470209 | 5.00 |
| 2572 | Concentration of medium VLDL particles | GCST90499017 | 5.00 |
| 2573 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499922 | 5.00 |
| 2574 | Paracetamol of NSAID medication | FING00001145 | 5.00 |
| 2575 | MIA/NBL1 ratio | GCST90315445 | 4.99 |
| 2576 | F13B levels | GCST90469167 | 4.99 |
| 2577 | Triglycerides to Total Lipids in IDL percentage | GCST90497676 | 4.99 |
| 2578 | Monounsaturated fatty acids to total fatty acids percentage | GCST90499109 | 4.99 |
| 2579 | IDP dMRI TBSS FA Uncinate fasciculus L | GCST90003922 | 4.99 |
| 2580 | ANXA1 levels | GCST90468316 | 4.99 |
| 2581 | IDP T1 SIENAX CSF normalised volume | GCST90002428 | 4.98 |
| 2582 | Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763) | GCST90476268 | 4.98 |
| 2583 | Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels | GCST90200098 | 4.98 |
| 2584 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105 | ECGU000105 | 4.97 |
| 2585 | MUC16 levels | GCST90469964 | 4.97 |
| 2586 | PTPRF/SDC1 ratio | GCST90315752 | 4.97 |
| 2587 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339 | ECGU000339 | 4.96 |
| 2588 | ROBO1 levels | GCST90470489 | 4.95 |
| 2589 | IPCEF1/TBCB ratio | GCST90315187 | 4.95 |
| 2590 | Cholesterol in medium LDL (UKB data field 23540) | GCST90269637 | 4.95 |
| 2591 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336 | ECGU000336 | 4.95 |
| 2592 | Diastolic blood pressure, manual reading | Blood pressure | UKBB00000180 | 4.94 |
| 2593 | FAM3C/NECTIN2 ratio | GCST90314781 | 4.94 |
| 2594 | COL6A3/OGN ratio | GCST90314177 | 4.94 |
| 2595 | Triglyceride to phosphoglyceride ratio | GCST90499992 | 4.93 |
| 2596 | Saturated fatty acids to total fatty acids percentage | GCST90502207 | 4.93 |
| 2597 | DPP6/SEZ6L ratio | GCST90314544 | 4.92 |
| 2598 | Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels | GCST90060298 | 4.92 |
| 2599 | Triacylglycerol_52:5_[M+NH4]1+ levels | GCST90060506 | 4.92 |
| 2600 | FCN2 levels | GCST90469204 | 4.91 |
| 2601 | SNAP25 levels | GCST90470691 | 4.90 |
| 2602 | CASP3/SERPINB9 ratio | GCST90313642 | 4.90 |
| 2603 | TNFRSF12A levels | GCST90470904 | 4.90 |
| 2604 | FOLR3 levels | GCST90469261 | 4.89 |
| 2605 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476365 | 4.89 |
| 2606 | IL6ST/PDGFRA ratio | GCST90315169 | 4.89 |
| 2607 | TNFSF10 levels | GCST90470917 | 4.89 |
| 2608 | CETN2/PRTFDC1 ratio | GCST90314030 | 4.88 |
| 2609 | SPART levels | GCST90470719 | 4.88 |
| 2610 | PCDH17/THBD ratio | GCST90315607 | 4.88 |
| 2611 | PCBP2 levels | GCST90470167 | 4.88 |
| 2612 | Proline levels | GCST90243457 | 4.88 |
| 2613 | PPM1B levels | GCST90470296 | 4.88 |
| 2614 | Whole grain cereal liking | GCST90094869 | 4.88 |
| 2615 | Phospholipid levels in large VLDL | GCST90092876 | 4.87 |
| 2616 | F3 levels | GCST90469170 | 4.87 |
| 2617 | ThalamNuclei lh volume PuI | GCST90002714 | 4.87 |
| 2618 | Total free cholesterol levels | GCST90500072 | 4.87 |
| 2619 | IL1RL2 levels | GCST90469575 | 4.87 |
| 2620 | aparc-a2009s rh volume S-subparietal | GCST90003069 | 4.87 |
| 2621 | IDP dMRI TBSS L3 Cerebral peduncle R | GCST90004185 | 4.86 |
| 2622 | RGMB/THY1 ratio | GCST90315771 | 4.86 |
| 2623 | Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levels | GCST90318013 | 4.86 |
| 2624 | FAM171B levels | GCST90090339 | 4.86 |
| 2625 | Omega-6 fatty acid levels | GCST90502515 | 4.85 |
| 2626 | rfMRI connectivity (ICA100 edge 931) | GCST90005784 | 4.85 |
| 2627 | NPL levels | GCST90470072 | 4.84 |
| 2628 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179 | ECGU000179 | 4.84 |
| 2629 | SCARF2 levels | GCST90470537 | 4.84 |
| 2630 | SH2B3/SUGT1 ratio | GCST90315840 | 4.84 |
| 2631 | Multi-trait sum score | GCST90270119 | 4.84 |
| 2632 | ALDH1A1/RBKS ratio | GCST90313247 | 4.84 |
| 2633 | LTA4H levels | GCST90469812 | 4.83 |
| 2634 | FOLR2 levels | GCST90469260 | 4.83 |
| 2635 | IGF1 levels | UKBB00000337 | 4.83 |
| 2636 | Metabolic disorder, other/unspecified | FING00000815 | 4.82 |
| 2637 | Phospholipids to Total Lipids in Very Small VLDL percentage | GCST90500866 | 4.82 |
| 2638 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166 | ECGA000166 | 4.81 |
| 2639 | IDP SWI T2star left putamen | GCST90003867 | 4.81 |
| 2640 | HSPB1/PLIN3 ratio | GCST90315088 | 4.80 |
| 2641 | IL6ST/LEPR ratio | GCST90315165 | 4.80 |
| 2642 | LAT2 levels | GCST90469739 | 4.80 |
| 2643 | Other diseases of the digestive system | FING00001010 | 4.79 |
| 2644 | BA-exvivo rh area BA4p | GCST90003226 | 4.79 |
| 2645 | IDP T1 FIRST right putamen volume | GCST90002441 | 4.79 |
| 2646 | CHRDL1/SMOC2 ratio | GCST90314062 | 4.78 |
| 2647 | Linoleic acid levels | GCST90502295 | 4.78 |
| 2648 | Chronic airway obstruction | respiratory | UKBB00000135 | 4.78 |
| 2649 | CPB1/PRSS2 ratio | GCST90314211 | 4.77 |
| 2650 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T27 | ECGA000027 | 4.77 |
| 2651 | Phospholipids in LDL | GCST90498439 | 4.77 |
| 2652 | CD200R1 levels | GCST90468605 | 4.77 |
| 2653 | CGREF1 levels | GCST90468735 | 4.77 |
| 2654 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T318 | ECGU000318 | 4.77 |
| 2655 | IDP T1 SIENAX CSF unnormalised volume | GCST90002429 | 4.76 |
| 2656 | FADD levels | GCST90469180 | 4.76 |
| 2657 | SMAD5 levels | GCST90470678 | 4.76 |
| 2658 | ATRN levels | GCST90468400 | 4.76 |
| 2659 | Monounsaturated fatty acids to total fatty acids percentage | GCST90499111 | 4.76 |
| 2660 | TNFSF12 levels | GCST90470919 | 4.75 |
| 2661 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T406 | ECGU000406 | 4.75 |
| 2662 | Cholesterol levels in large VLDL | GCST90092868 | 4.75 |
| 2663 | CNTN3 levels | GCST90468805 | 4.75 |
| 2664 | Number in household | Household | UKBB00000530 | 4.74 |
| 2665 | IDP dMRI TBSS ICVF Cingulum hippocampus L | GCST90004364 | 4.74 |
| 2666 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169 | ECGA000169 | 4.74 |
| 2667 | CXCL11/CXCL13 ratio | GCST90314333 | 4.74 |
| 2668 | FCRL2/KLB ratio | GCST90314798 | 4.74 |
| 2669 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T126 | ECGU000126 | 4.73 |
| 2670 | IDP dMRI ProbtrackX MD ptr r | GCST90004239 | 4.73 |
| 2671 | Polyunsaturated fatty acid levels | GCST90502606 | 4.73 |
| 2672 | KIRREL2 levels | GCST90469690 | 4.73 |
| 2673 | Obstructive chronic bronchitis | respiratory | UKBB00000546 | 4.73 |
| 2674 | Chronic bronchitis | respiratory | UKBB00000136 | 4.72 |
| 2675 | Syncope and collapse | symptoms | UKBB00000801 | 4.72 |
| 2676 | REG1A/REG4 ratio | GCST90315762 | 4.72 |
| 2677 | AREG levels | GCST90468347 | 4.72 |
| 2678 | Myocardial infarction | GCST90018657 | 4.72 |
| 2679 | CX3CL1 levels | GCST90274778 | 4.71 |
| 2680 | aparc-DKTatlas lh volume rostralmiddlefrontal | GCST90002887 | 4.71 |
| 2681 | CNTNAP2 levels | GCST90468808 | 4.71 |
| 2682 | DTI TBSS MD Retrolenticular part of internal capsule R | GCST90384592 | 4.71 |
| 2683 | Cholesteryl Esters to Total Lipids in Large VLDL percentage | GCST90498162 | 4.70 |
| 2684 | CCL25 levels | GCST90274768 | 4.70 |
| 2685 | Principal component-derived dietary pattern 28 | GCST90133033 | 4.70 |
| 2686 | AmygNuclei lh volume Central-nucleus | GCST90002652 | 4.70 |
| 2687 | ACP5 levels | GCST90468203 | 4.70 |
| 2688 | PLAUR levels | GCST90470251 | 4.70 |
| 2689 | KLK13 levels | GCST90469699 | 4.69 |
| 2690 | Mean corpuscular hemoglobin | GCST90002323 | 4.69 |
| 2691 | Waist circumference | GCST90103753 | 4.68 |
| 2692 | BLMH levels | GCST90468447 | 4.68 |
| 2693 | DNAJC9 levels | GCST90469018 | 4.68 |
| 2694 | IDP dMRI TBSS MD Middle cerebellar peduncle | GCST90004027 | 4.68 |
| 2695 | FAM172A levels | GCST90469184 | 4.68 |
| 2696 | Fatty acid(20:3)_[M-H]1- levels | GCST90060117 | 4.68 |
| 2697 | Total fatty acid levels | GCST90500053 | 4.68 |
| 2698 | Cholesterol to Total Lipids in Large VLDL percentage | GCST90498125 | 4.67 |
| 2699 | X-11787 levels | GCST90200465 | 4.67 |
| 2700 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21 | ECGA000021 | 4.67 |
| 2701 | CD40LG/SERPINE1 ratio | GCST90313826 | 4.67 |
| 2702 | IRAK4 levels | GCST90469628 | 4.67 |
| 2703 | FCGR2B/NOS3 ratio | GCST90314794 | 4.67 |
| 2704 | CNDP1/F9 ratio | GCST90314147 | 4.67 |
| 2705 | Concentration of medium LDL particles (UKB data field 23537) | GCST90269634 | 4.67 |
| 2706 | Operation code - spine or back surgery | Operations | UKBB00000565 | 4.66 |
| 2707 | IDP dMRI TBSS L2 Cerebral peduncle R | GCST90004137 | 4.66 |
| 2708 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282 | ECGA000282 | 4.66 |
| 2709 | CTRC levels | GCST90468906 | 4.66 |
| 2710 | BA-exvivo rh area perirhinal | GCST90003233 | 4.66 |
| 2711 | Miserableness | Mental health | UKBB00000478 | 4.66 |
| 2712 | Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney disease | GCST90266016 | 4.65 |
| 2713 | Left ventricular end diastolic mass end diastolic volume ratio | GCST90268131 | 4.65 |
| 2714 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87 | ECGA000087 | 4.65 |
| 2715 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T355 | ECGA000355 | 4.65 |
| 2716 | Physical activity (Total log acceleration 2am-4am) | GCST90061410 | 4.65 |
| 2717 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T132 | ECGA000132 | 4.65 |
| 2718 | CPPED1 levels | GCST90468845 | 4.65 |
| 2719 | PODXL levels | GCST90470280 | 4.65 |
| 2720 | Alkenylphosphatidylethanolamine (P-20:0/18:2) levels | GCST90025056 | 4.64 |
| 2721 | Total phospholipid levels in lipoprotein particles | GCST90500124 | 4.64 |
| 2722 | APP/EGF ratio | GCST90313322 | 4.64 |
| 2723 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18 | ECGA000018 | 4.64 |
| 2724 | Total lipids in small VLDL | GCST90499840 | 4.64 |
| 2725 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48 | ECGA000048 | 4.64 |
| 2726 | Experiencing mood swings | GCST006944 | 4.64 |
| 2727 | AHSA1 levels | GCST90468262 | 4.64 |
| 2728 | Low-density lipoprotein levels (MTAG) | GCST90179148 | 4.64 |
| 2729 | ThalamNuclei rh volume VLp | GCST90002755 | 4.63 |
| 2730 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228 | ECGU000228 | 4.63 |
| 2731 | Triglyceride levels in very small VLDL | GCST90132669 | 4.62 |
| 2732 | Cataract (PheCode 366) | GCST90043785 | 4.62 |
| 2733 | Aortic aneurysm (PheCode 442.1) | GCST90475993 | 4.62 |
| 2734 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T173 | ECGA000173 | 4.62 |
| 2735 | aseg global volume BrainSegNotVentSurf | GCST90002592 | 4.62 |
| 2736 | EGFLAM levels | GCST90469084 | 4.62 |
| 2737 | VPS4B levels | GCST90471047 | 4.62 |
| 2738 | AHSP/HMBS ratio | GCST90313217 | 4.62 |
| 2739 | DAPP1/PMVK ratio | GCST90314396 | 4.62 |
| 2740 | Platelet count | Blood count | UKBB00000646 | 4.62 |
| 2741 | End-diastolic bi-ventricular shape (principal component 3) | GCST90448482 | 4.62 |
| 2742 | Hemangioma of skin and subcutaneous tissue (PheCode 228.1) | GCST90475633 | 4.61 |
| 2743 | TBCC levels | GCST90470814 | 4.61 |
| 2744 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225 | ECGU000225 | 4.61 |
| 2745 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490 | ECGA000490 | 4.61 |
| 2746 | Pain in joint | FING00001137 | 4.61 |
| 2747 | aparc-pial lh area lateraloccipital | GCST90003151 | 4.61 |
| 2748 | Mean corpuscular hemoglobin | GCST004630 | 4.61 |
| 2749 | Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levels | GCST90060375 | 4.61 |
| 2750 | CBLN4/RET ratio | GCST90313660 | 4.60 |
| 2751 | Omega-3 fatty acids levels | GCST90499145 | 4.60 |
| 2752 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T87 | ECGU000087 | 4.60 |
| 2753 | CIAPIN1/PLA2G4A ratio | GCST90314065 | 4.59 |
| 2754 | BA-exvivo lh volume entorhinal | GCST90002848 | 4.59 |
| 2755 | PDGFB levels | GCST90012016 | 4.59 |
| 2756 | STMN3 levels | GCST90242894 | 4.59 |
| 2757 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502373 | 4.59 |
| 2758 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T326 | ECGU000326 | 4.58 |
| 2759 | GPHA2 levels | GCST90469389 | 4.58 |
| 2760 | Gout | FING00000587 | 4.57 |
| 2761 | ALB levels | GCST90025992 | 4.57 |
| 2762 | CD163/MSR1 ratio | GCST90313738 | 4.57 |
| 2763 | Platelet count | GCST90278640 | 4.57 |
| 2764 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388 | ECGA000388 | 4.56 |
| 2765 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 4.56 |
| 2766 | AMIGO2 levels | GCST90468292 | 4.56 |
| 2767 | Concentration of large LDL particles | GCST90092863 | 4.56 |
| 2768 | High light scatter reticulocyte count | GCST90002385 | 4.55 |
| 2769 | Blood clot / pulmonary embolism / deep vein thrombosis (DVT) | GCST90475209 | 4.55 |
| 2770 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359 | ECGA000359 | 4.55 |
| 2771 | FBP1/GSTA1 ratio | GCST90314786 | 4.54 |
| 2772 | RFC4 levels | GCST90470460 | 4.54 |
| 2773 | Total lipids in small HDL | GCST90499456 | 4.54 |
| 2774 | Fed-up feelings | Mental health | UKBB00000242 | 4.54 |
| 2775 | Phospholipids to Total Lipids in Small VLDL percentage | GCST90499902 | 4.54 |
| 2776 | PCDH9 levels | GCST90470172 | 4.54 |
| 2777 | Polyunsaturated fatty acid levels | GCST90502607 | 4.53 |
| 2778 | Osteoarthrosis NOS | musculoskeletal | UKBB00000597 | 4.53 |
| 2779 | IDP dMRI ProbtrackX L2 ar l | GCST90004273 | 4.53 |
| 2780 | GLB1 levels | GCST90469355 | 4.53 |
| 2781 | CRADD/FKBP4 ratio | GCST90314238 | 4.52 |
| 2782 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49 | ECGA000049 | 4.52 |
| 2783 | Left ventricular end diastole inferoseptal wall thickness | GCST90278514 | 4.52 |
| 2784 | Total lipids in large VLDL | GCST90498216 | 4.52 |
| 2785 | Left-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302740 | 4.52 |
| 2786 | Parental longevity (father's age at death) | GCST006700 | 4.52 |
| 2787 | ACVRL1/TNFRSF19 ratio | GCST90313159 | 4.52 |
| 2788 | Saturated fatty acids to total fatty acids percentage | GCST90499966 | 4.52 |
| 2789 | Free cholesterol in medium VLDL (UKB data field 23507) | GCST90269604 | 4.52 |
| 2790 | Reticulocyte count | GCST90025972 | 4.52 |
| 2791 | Dihexosylceramide (d18:1/24:0) levels | GCST90025349 | 4.51 |
| 2792 | SPARCL1 levels | GCST90470717 | 4.50 |
| 2793 | CCL13/CCL8 ratio | GCST90313676 | 4.50 |
| 2794 | MCFD2 levels | GCST90469873 | 4.50 |
| 2795 | Other arthrosis | FING00000965 | 4.50 |
| 2796 | CMIP levels | GCST90468795 | 4.49 |
| 2797 | GSTT2B levels | GCST90469415 | 4.49 |
| 2798 | BAG6/USP8 ratio | GCST90313451 | 4.49 |
| 2799 | Total Lipids in VLDL | GCST90500234 | 4.48 |
| 2800 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248 | ECGU000248 | 4.48 |
| 2801 | GPA33 levels | GCST90469385 | 4.48 |
| 2802 | Sphingomyelin_40:0_[M+H]1+ levels | GCST90060364 | 4.47 |
| 2803 | Triacylglycerol (54:2) [NL-18:0] levels | GCST90025175 | 4.47 |
| 2804 | CPA1/PRSS2 ratio | GCST90314206 | 4.47 |
| 2805 | C1S levels | GCST90468494 | 4.47 |
| 2806 | Platelet distribution width | GCST004616 | 4.47 |
| 2807 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390 | ECGU000390 | 4.47 |
| 2808 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T411 | ECGU000411 | 4.46 |
| 2809 | Triacylglycerol_54:7_[M+NH4]1+ levels | GCST90060536 | 4.46 |
| 2810 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497969 | 4.46 |
| 2811 | APOB levels | GCST90092809 | 4.46 |
| 2812 | IDP dMRI TBSS ICVF Superior cerebellar peduncle R | GCST90004339 | 4.46 |
| 2813 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6 | ECGA000006 | 4.45 |
| 2814 | Free cholesterol in medium LDL (UKB data field 23542) | GCST90269639 | 4.45 |
| 2815 | ELAC1 levels | GCST90469101 | 4.45 |
| 2816 | total cholesterol (minimum, inv-norm transformed) | GCST90476427 | 4.45 |
| 2817 | Plateletcrit | GCST90002400 | 4.45 |
| 2818 | IL16/NADK ratio | GCST90315152 | 4.45 |
| 2819 | LTBP3 levels | GCST90469815 | 4.45 |
| 2820 | IDP dMRI TBSS ICVF Middle cerebellar peduncle | GCST90004327 | 4.44 |
| 2821 | Hematocrit | GCST90002305 | 4.44 |
| 2822 | Hemoglobin | GCST90278631 | 4.44 |
| 2823 | Carotid plaque | GCST007435 | 4.44 |
| 2824 | Facial skin colour (CIELAB index b* value) | GCST90020056 | 4.43 |
| 2825 | EFNB2 levels | GCST90469082 | 4.43 |
| 2826 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168 | ECGA000168 | 4.43 |
| 2827 | Body fat percentage | GCST007064 | 4.43 |
| 2828 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88 | ECGA000088 | 4.43 |
| 2829 | aparc-DKTatlas rh volume lateraloccipital | GCST90002902 | 4.42 |
| 2830 | Hearing aid user | Hearing | UKBB00000309 | 4.42 |
| 2831 | CDKN1A/NCK2 ratio | GCST90313973 | 4.42 |
| 2832 | Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) | GCST90269733 | 4.41 |
| 2833 | Follicular cysts of skin and subcutaneous tissue | FING00000547 | 4.41 |
| 2834 | Bundle branch block (PheCode 426.3) | GCST90475956 | 4.41 |
| 2835 | Cooked vegetables consumption | GCST90132977 | 4.41 |
| 2836 | Ratio of triglycerides to phosphoglycerides | GCST90092983 | 4.41 |
| 2837 | Loud music exposure frequency | Hearing | UKBB00000410 | 4.40 |
| 2838 | Total lipids in medium VLDL (UKB data field 23503) | GCST90269600 | 4.39 |
| 2839 | 4-acetamidobutanoate levels | GCST90243440 | 4.39 |
| 2840 | ITGB5/VSIR ratio | GCST90315235 | 4.39 |
| 2841 | NMNAT1 levels | GCST90470057 | 4.39 |
| 2842 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285 | ECGA000285 | 4.39 |
| 2843 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levels | GCST90200075 | 4.39 |
| 2844 | CLTA levels | GCST90468791 | 4.39 |
| 2845 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499335 | 4.38 |
| 2846 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T360 | ECGU000360 | 4.38 |
| 2847 | Plateletcrit | GCST004607 | 4.38 |
| 2848 | CTSC/PLA2G15 ratio | GCST90314311 | 4.38 |
| 2849 | DTI autoptx L2 ilf r tract | GCST90385181 | 4.38 |
| 2850 | LAMP1 levels | GCST90469733 | 4.38 |
| 2851 | F9/FURIN ratio | GCST90314747 | 4.38 |
| 2852 | rfMRI amplitudes (ICA100 node 45) | GCST90004633 | 4.38 |
| 2853 | HDL cholesterol | GCST000755 | 4.38 |
| 2854 | Asphyxia and hypoxemia (PheCode 1013) | GCST90475559 | 4.38 |
| 2855 | aseg global volume CC-Posterior | GCST90002607 | 4.37 |
| 2856 | Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditions | UKBB00000519 | 4.37 |
| 2857 | High light scatter reticulocyte percentage of red cells | GCST90002386 | 4.37 |
| 2858 | LILRB1 levels | GCST90469776 | 4.37 |
| 2859 | 1-methylhistidine levels | GCST90199691 | 4.37 |
| 2860 | IDP dMRI TBSS ICVF Anterior corona radiata L | GCST90004350 | 4.37 |
| 2861 | aparc-Desikan rh volume parahippocampal | GCST90002816 | 4.37 |
| 2862 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T338 | ECGA000338 | 4.36 |
| 2863 | P4HB/PPP1R12A ratio | GCST90315591 | 4.36 |
| 2864 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T29 | ECGA000029 | 4.36 |
| 2865 | Other forms of systemic lupus erythematosus | FING00001051 | 4.35 |
| 2866 | Hippocampal right GC-ML-DG volume (head) | GCST90267968 | 4.35 |
| 2867 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 4.35 |
| 2868 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131 | ECGU000131 | 4.35 |
| 2869 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176 | ECGA000176 | 4.34 |
| 2870 | 1-arachidonoylglycerophosphoethanolamine levels | GCST90243808 | 4.34 |
| 2871 | Reaction time | GCST003499 | 4.34 |
| 2872 | NMT1 levels | GCST90470059 | 4.34 |
| 2873 | CA4/SELE ratio | GCST90313587 | 4.34 |
| 2874 | Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary Administration | UKBB00000837 | 4.33 |
| 2875 | Arthrosis | FING00000111 | 4.33 |
| 2876 | Plum liking | GCST90094812 | 4.33 |
| 2877 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20 | ECGA000020 | 4.33 |
| 2878 | aseg global volume CSF | GCST90002603 | 4.33 |
| 2879 | Arterial embolism and thrombosis of lower extremity artery | FING00000106 | 4.33 |
| 2880 | FRZB levels | GCST90469269 | 4.33 |
| 2881 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T207 | ECGU000207 | 4.32 |
| 2882 | Rotator cuff syndrome | FING00001270 | 4.32 |
| 2883 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365 | ECGA000365 | 4.32 |
| 2884 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90476004 | 4.32 |
| 2885 | Cholesterol to total lipids ratio in large HDL | GCST90092845 | 4.32 |
| 2886 | Phospholipids in medium VLDL (UKB data field 23504) | GCST90269601 | 4.32 |
| 2887 | Triacylglycerol_52:2_[M+NH4]1+ levels | GCST90060511 | 4.32 |
| 2888 | CRNN levels | GCST90277890 | 4.32 |
| 2889 | SERPINE1/SPARC ratio | GCST90315834 | 4.31 |
| 2890 | Age started wearing glasses or contact lenses | Eyesight | UKBB00000017 | 4.31 |
| 2891 | TNC levels | GCST90470895 | 4.31 |
| 2892 | PACS2 levels | GCST90470141 | 4.31 |
| 2893 | GLOD4/HSPA1A ratio | GCST90314937 | 4.31 |
| 2894 | Serum copper levels | GCST90100524 | 4.31 |
| 2895 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364 | ECGA000364 | 4.31 |
| 2896 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415 | ECGU000415 | 4.31 |
| 2897 | Body fat percentage | GCST90103752 | 4.30 |
| 2898 | Type of accommodation lived in - A house or bungalow | Household | UKBB00000869 | 4.30 |
| 2899 | Total Lipids in VLDL | GCST90500236 | 4.29 |
| 2900 | MPHOSPH8 levels | GCST90469934 | 4.29 |
| 2901 | GFER/VASH1 ratio | GCST90314922 | 4.29 |
| 2902 | aseg global volume EstimatedTotalIntraCranial | GCST90002597 | 4.29 |
| 2903 | Other hearing loss | FING00001056 | 4.29 |
| 2904 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 4.28 |
| 2905 | ThalamNuclei rh volume MDl | GCST90002748 | 4.28 |
| 2906 | PRAP1 levels | GCST90470312 | 4.28 |
| 2907 | SRPX levels | GCST90470744 | 4.28 |
| 2908 | ADGRE2/IFNGR1 ratio | GCST90313177 | 4.27 |
| 2909 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T356 | ECGA000356 | 4.27 |
| 2910 | CASP3 levels | GCST90468545 | 4.27 |
| 2911 | BMI (weighted GWA) | GCST90267269 | 4.27 |
| 2912 | Pregnenetriol sulfate levels | GCST90200241 | 4.27 |
| 2913 | PPP1R2 levels | GCST90470304 | 4.26 |
| 2914 | F-meat liking (derived food-liking factor) | GCST90094799 | 4.26 |
| 2915 | IL6ST/LIFR ratio | GCST90315166 | 4.26 |
| 2916 | Androstenediol (3beta,17beta) monosulfate (1) levels | GCST90199872 | 4.26 |
| 2917 | CST6/GAL ratio | GCST90314302 | 4.25 |
| 2918 | IDP dMRI TBSS OD Anterior limb of internal capsule R | GCST90004418 | 4.25 |
| 2919 | Mood [affective] disorders | FING00000836 | 4.25 |
| 2920 | LY75 levels | GCST90469822 | 4.25 |
| 2921 | Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500716 | 4.25 |
| 2922 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361 | ECGA000361 | 4.25 |
| 2923 | IDP dMRI TBSS L1 Cingulum cingulate gyrus R | GCST90004109 | 4.25 |
| 2924 | COL1A1 levels | GCST90468813 | 4.25 |
| 2925 | ROBO2 levels | GCST90470490 | 4.24 |
| 2926 | CASP10/ING1 ratio | GCST90313625 | 4.24 |
| 2927 | Platelet crit | Blood count | UKBB00000647 | 4.24 |
| 2928 | PDGFB levels | GCST90470189 | 4.24 |
| 2929 | Other diseases of urinary system | FING00001013 | 4.24 |
| 2930 | HippSubfield lh volume Whole-hippocampus | GCST90002689 | 4.23 |
| 2931 | Disorders of lipoprotein metabolism and other lipidaemias | Metabolic disorders | UKBB00000186 | 4.23 |
| 2932 | CD79B/CKAP4 ratio | GCST90313898 | 4.23 |
| 2933 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T349 | ECGA000349 | 4.23 |
| 2934 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T127 | ECGU000127 | 4.23 |
| 2935 | COLEC12/TNFRSF1A ratio | GCST90314187 | 4.23 |
| 2936 | BCR/PLXNA4 ratio | GCST90313497 | 4.23 |
| 2937 | Disorders of lipoid metabolism | endocrine/metabolic | UKBB00000185 | 4.22 |
| 2938 | Polyneuropathy in diabetes (PheCode 250.6) | GCST90475686 | 4.22 |
| 2939 | Free cholesterol to total lipids in small HDL percentage (UKB data field 23647) | GCST90269744 | 4.22 |
| 2940 | CKAP4 levels | GCST90468758 | 4.22 |
| 2941 | Hyperlipidemia | endocrine/metabolic | UKBB00000333 | 4.21 |
| 2942 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389 | ECGA000389 | 4.21 |
| 2943 | triglyceride (minimum, inv-norm transformed) | GCST90476437 | 4.21 |
| 2944 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90024188 | 4.21 |
| 2945 | IL32 levels | GCST90469591 | 4.21 |
| 2946 | Triacylglycerol_52:1_[M+NH4]1+ levels | GCST90060515 | 4.21 |
| 2947 | SEMA4D/TXNDC5 ratio | GCST90315824 | 4.20 |
| 2948 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499831 | 4.20 |
| 2949 | BA-exvivo lh area entorhinal | GCST90003220 | 4.20 |
| 2950 | AMY2A levels | GCST90468298 | 4.19 |
| 2951 | Cholesteryl Esters to Total Lipids in Very Small VLDL percentage | GCST90500754 | 4.19 |
| 2952 | IDP dMRI ProbtrackX ICVF ar l | GCST90004375 | 4.19 |
| 2953 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181 | ECGU000181 | 4.19 |
| 2954 | Other chronic obstructive pulmonary disease | Chronic lower respiratory diseases | UKBB00000604 | 4.19 |
| 2955 | Nonalcoholic fatty liver disease | FING00000878 | 4.19 |
| 2956 | TNFSF11 levels | GCST90012044 | 4.19 |
| 2957 | Mineral and other dietary supplements - Zinc | Medication | UKBB00000476 | 4.18 |
| 2958 | FKBP5 levels | GCST90469244 | 4.18 |
| 2959 | Takes medication for peripheral vascular disease? | GCST90475220 | 4.18 |
| 2960 | CD28 levels | GCST90468616 | 4.18 |
| 2961 | Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney disease | GCST90264321 | 4.18 |
| 2962 | DTI autoptx MD slf r tract | GCST90385242 | 4.18 |
| 2963 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498976 | 4.17 |
| 2964 | MEGF9/OXT ratio | GCST90315419 | 4.17 |
| 2965 | Other embolism and thrombosis | FING00001043 | 4.17 |
| 2966 | GHR levels | GCST90469342 | 4.17 |
| 2967 | SERPINA11 levels | GCST90470580 | 4.17 |
| 2968 | SELP/VSIR ratio | GCST90315822 | 4.16 |
| 2969 | APOM levels | GCST90468342 | 4.16 |
| 2970 | WFIKKN1 levels | GCST90471076 | 4.16 |
| 2971 | MMP8/PGLYRP1 ratio | GCST90315465 | 4.16 |
| 2972 | IDS levels | GCST90469507 | 4.16 |
| 2973 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145 | ECGA000145 | 4.15 |
| 2974 | RGCC levels | GCST90470461 | 4.14 |
| 2975 | DNAJA2/PRDX5 ratio | GCST90314506 | 4.14 |
| 2976 | Triacylglycerol_50:2_[M+NH4]1+ levels | GCST90060473 | 4.14 |
| 2977 | aparc-Desikan rh volume lateraloccipital | GCST90002811 | 4.14 |
| 2978 | CPA2 levels | GCST90468837 | 4.14 |
| 2979 | Platelet crit (UKB data field 30090) | GCST90468096 | 4.14 |
| 2980 | PEAR1/SCARF1 ratio | GCST90315642 | 4.14 |
| 2981 | FCGR2A/FCGR2B ratio | GCST90314793 | 4.13 |
| 2982 | IDP dMRI TBSS ICVF Sagittal stratum R | GCST90004357 | 4.13 |
| 2983 | Total Cholesteryl ester levels | GCST90025188 | 4.13 |
| 2984 | Total lipids in IDL | GCST90497594 | 4.13 |
| 2985 | PEAR1/TREML2 ratio | GCST90315645 | 4.13 |
| 2986 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17 | ECGA000017 | 4.12 |
| 2987 | Operative procedures - No procedure performed | Summary Operations | UKBB00000584 | 4.12 |
| 2988 | FOLH1 levels | GCST90425661 | 4.12 |
| 2989 | IDP dMRI TBSS ISOVF Superior cerebellar peduncle L | GCST90004490 | 4.12 |
| 2990 | Concentration of medium VLDL particles (UKB data field 23502) | GCST90269599 | 4.12 |
| 2991 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T361 | ECGU000361 | 4.12 |
| 2992 | CDC37 levels | GCST90468665 | 4.12 |
| 2993 | IDP dMRI TBSS OD Superior corona radiata L | GCST90004427 | 4.12 |
| 2994 | Cardiovascular disease | GCST90086057 | 4.11 |
| 2995 | Cholesterol levels in small LDL | GCST90092956 | 4.11 |
| 2996 | DTI autoptx FA str r tract | GCST90385136 | 4.11 |
| 2997 | Thyroid stimulating hormone levels within normal range in pregnancy | GCST90435195 | 4.11 |
| 2998 | Thyroid stimulating hormone levels | GCST90296333 | 4.11 |
| 2999 | Total fatty acid levels | GCST90092987 | 4.11 |
| 3000 | Trouble falling asleep when you first go to bed | GCST90476385 | 4.11 |